Surajit Karmakar
- Molecular Biology top 10%
- Biomaterials top 2%
- Biomedical Engineering top 5%
- Materials Chemistry top 10%
- Molecular Medicine top 1%
- Co-authors
- Naren L. BanikSwapan K. RaySubhasree Roy ChoudhuryAtul DevChengzhong YuSunil J. PatelAnup K. SrivastavaMohammed Nadim Sardoiwala
- Topics
- Nanoparticle-Based Drug Delivery (14 papers)Cell death mechanisms and regulation (13 papers)Neuroblastoma Research and Treatments (10 papers)
- Partner nations
- IndiaUnited StatesAustralia
In The Last Decade
Surajit Karmakar
78 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 136
- Molecular Biology 993
- Biomaterials 552
- Biomedical Engineering 516
- Materials Chemistry 459
- Molecular Medicine 308
Countries citing papers authored by Surajit Karmakar
This map shows the geographic impact of Surajit Karmakar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Surajit Karmakar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Surajit Karmakar more than expected).
Fields of papers citing papers by Surajit Karmakar
This network shows the impact of papers produced by Surajit Karmakar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Surajit Karmakar. The network helps show where Surajit Karmakar may publish in the future.
Co-authorship network of co-authors of Surajit Karmakar
This figure shows the co-authorship network connecting the top 25 collaborators of Surajit Karmakar. A scholar is included among the top collaborators of Surajit Karmakar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Surajit Karmakar. Surajit Karmakar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 12 | |
| 6 | 23 | |
| 7 | 6 | |
| 8 | 86 | |
| 9 | 37 | |
| 10 | 42 | |
| 11 | 58 | |
| 12 | 89 | |
| 13 | 14 | |
| 14 | 15 | |
| 15 | Treatment with combination of all-trans retinoic acid and interferon-gamma regressed human glioblastoma T98G xenografts in nude mice | 0 |
| 16 | 25 | |
| 17 | 77 | |
| 18 | 84 | |
| 19 | 56 | |
| 20 | 85 |
About Surajit Karmakar
Surajit Karmakar is a scholar working on Neurology, Biomaterials and Molecular Medicine, having authored 84 papers that have together received 2.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (14 papers), Cell death mechanisms and regulation (13 papers) and Neuroblastoma Research and Treatments (10 papers). The work is most often cited by research in Molecular Medicine (308 citations), Biomaterials (552 citations) and Pharmaceutical Science (227 citations). Surajit Karmakar has collaborated with scholars based in India, United States and Australia. Frequent co-authors include Naren L. Banik, Swapan K. Ray, Subhasree Roy Choudhury, Atul Dev, Chengzhong Yu, Sunil J. Patel, Anup K. Srivastava, Mohammed Nadim Sardoiwala, Amirali Popat and Siddharth Jambhrunkar. Their work appears in journals such as The Science of The Total Environment, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.